OBJECTIVE: To evaluate the psychometric properties of the 12-item Medical Outcomes Study (MOS) Short-Form Health Status Survey (SF-12) (Hebrew version) in a large primary care patient sample in Israel. SUBJECTS: The sample comprised 3631 adult primary care patients who were screened for depression in a longitudinal design. MEASURES: SF-12 yielding two scores: the Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12). For comparison, the Center for Epidemiological Studies - Depression scale (CES-D), two subscales from the 90-item Hopkins Symptom Scale (SCL-90), Quality of Life Depression Scale (QLDS), World Health Organization Quality of Life Measure - Bref (WHOQoL-Bref), and interviewer-administered Composite International Diagnostic Interview (CIDI) were also administered. RESULTS: Score distribution was satisfactory, the amount of missing data was minimal and item-to-item correlations were satisfactory. Floor and ceiling effects were minimal in items with more than three response options. A confirmatory factor analysis supported the two-dimensional model of health. Test-retest reliability was good for both summary scales in a nondepressed population and for PCS-12 in the depressed population, but only moderate for MCS-12 in the depressed population. In regard to convergent validity, MCS-12 correlated negatively and significantly with the CES-D, QLDS, and two SCL-90 anxiety subscales, and positively and significantly with four WHOQoL-Bref domains. PCS-12 correlated positively and significantly with the WHOQoL-Bref physical domain. Discriminative validity was established in that both PCS-12 and MCS-12 showed meaningful effect sizes between groups with various degrees of physical and mental health problems. Sensitivity to change was established in that both PCS-12 and MCS-12 change scores were significantly different in subjects who had been depressed but were no longer so, as compared with those who were still depressed at follow-up. CONCLUSIONS: The SF-12 (Hebrew version) is a reliable and valid measure, particularly in a nondepressed population.
OBJECTIVE: To evaluate the psychometric properties of the 12-item Medical Outcomes Study (MOS) Short-Form Health Status Survey (SF-12) (Hebrew version) in a large primary care patient sample in Israel. SUBJECTS: The sample comprised 3631 adult primary care patients who were screened for depression in a longitudinal design. MEASURES: SF-12 yielding two scores: the Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12). For comparison, the Center for Epidemiological Studies - Depression scale (CES-D), two subscales from the 90-item Hopkins Symptom Scale (SCL-90), Quality of Life Depression Scale (QLDS), World Health Organization Quality of Life Measure - Bref (WHOQoL-Bref), and interviewer-administered Composite International Diagnostic Interview (CIDI) were also administered. RESULTS: Score distribution was satisfactory, the amount of missing data was minimal and item-to-item correlations were satisfactory. Floor and ceiling effects were minimal in items with more than three response options. A confirmatory factor analysis supported the two-dimensional model of health. Test-retest reliability was good for both summary scales in a nondepressed population and for PCS-12 in the depressed population, but only moderate for MCS-12 in the depressed population. In regard to convergent validity, MCS-12 correlated negatively and significantly with the CES-D, QLDS, and two SCL-90 anxiety subscales, and positively and significantly with four WHOQoL-Bref domains. PCS-12 correlated positively and significantly with the WHOQoL-Bref physical domain. Discriminative validity was established in that both PCS-12 and MCS-12 showed meaningful effect sizes between groups with various degrees of physical and mental health problems. Sensitivity to change was established in that both PCS-12 and MCS-12 change scores were significantly different in subjects who had been depressed but were no longer so, as compared with those who were still depressed at follow-up. CONCLUSIONS: The SF-12 (Hebrew version) is a reliable and valid measure, particularly in a nondepressed population.
Authors: Carolyn I Rodriguez; Helen Blair Simpson; Shang-Min Liu; Amanda Levinson; Carlos Blanco Journal: J Nerv Ment Dis Date: 2013-09 Impact factor: 2.254
Authors: Alfredo J Selim; William Rogers; John A Fleishman; Shirley X Qian; Benjamin G Fincke; James A Rothendler; Lewis E Kazis Journal: Qual Life Res Date: 2008-12-03 Impact factor: 4.147
Authors: Qiang Huang; Zong Ke Zhou; Bin Shen; Xiao Bo Yang; Yong Li; Peng De Kang; Jing Yang; Fu Xing Pei Journal: Rheumatol Int Date: 2012-05-08 Impact factor: 2.631
Authors: Martin Aigner; Sophie Förster-Streffleur; Wolfgang Prause; Marion Freidl; Maria Weiss; Michael Bach Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2006-01-01 Impact factor: 4.328
Authors: Eric Yuk Fai Wan; Edmond Pui Hang Choi; Esther Yee Tak Yu; Weng Yee Chin; Colman Siu Cheung Fung; Anca Ka Chun Chan; Cindy Lo Kuen Lam Journal: Qual Life Res Date: 2018-06-13 Impact factor: 4.147